Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

s_blt_2017a_2017-03-15t14:02:09z2 Hearing Summary

Date: 03/15/2017

Location: SCR 354

Final

BILL SUMMARY for SB17-203



SENATE COMMITTEE ON BUSINESS, LABOR, & TECHNOLOGY


Votes: View--> Action Taken:
Adopt amendment L.013. The motion passed on a vote

Refer Senate Bill 17-203, as amended, to the Commi
PASS

PASS







02:19 PM -- SB
17-203



Senator Todd introduced Senate Bill 17-203, concerning the prohibition against a carrier requiring a covered person to undergo step therapy. The bill prohibits health insurance carriers from requiring a covered person to undergo step therapy when being treated for a terminal condition or if the covered person has tried a step therapy required drug under a health benefit plan and the drug was discontinued by the manufacturer. A carrier that uses step therapy must have an override process by which a health care provider can demonstrate that the carrier's preferred drug is contraindicated or will likely cause an adverse reaction that will harm the covered person.



The bill defines step therapy as a protocol that requires a covered person to use a prescription drug, or sequence of prescription drugs, other than the drug recommended by the covered persons' health care provider, prior to the carrier providing coverage for the recommended drug.



Senator Todd provided a handout of materials to the committee (Attachment D).



170315 AttachD.pdf170315 AttachD.pdf



02:30 PM --
Carrie Nolan, Multiple Sclerosis Society, spoke in favor of the bill.



02:35 PM --
Dr. Lynn Parry, Multiple Sclerosis Society, spoke in favor of the bill.



02:38 PM --
Dr. Dan Scales, Rx Plus Pharmacy, spoke in favor of the bill. He responded to questions from the committee.



02:41 PM --
Dr. Robert Gross, representing himself, spoke in favor of the bill. He responded to questions from the committee.



03:07 PM --
Rebecca Gillett, representing herself, spoke in favor of the bill. She responded to questions from the committee.



03:13 PM --
Heather Salisbury, representing herself, spoke in favor of the bill. She responded to questions from the committee.



03:24 PM --
Mariah Leach, representing herself, spoke in favor of the bill.



03:28 PM --
Sharon O'Hara, Chronic Care Collaborative, spoke in favor of the bill. She responded to questions from the committee.



03:39 PM --
Emily Zadvorny, Colorado Pharmacists Society, spoke in opposition to the bill.



03:44 PM --
Rachel Lee, CVS Health, spoke in opposition to the bill. She responded to questions from the committee.



03:53 PM --
Sara Orrange, Colorado Association of Health Plans, spoke in opposition to the bill. She responded to questions from the committee.



03:56 PM --
Virginia Love, America's Heath Insurance Plans, spoke in opposition to the bill. She responded to questions from the committee.



04:06 PM --
Michelle Beozzo, Denver Health Medical Plan, spoke in opposition to the bill.



04:10 PM --
Patrick Boyle, Express Scripts, spoke in opposition to the bill.



04:18 PM



Senator Todd made closing comments on the merits of the bill. Senator Priola distributed amendment L.013 (Attachment E) to the committee. Committee discussion ensued.


BILL: SB17-203
TIME: 04:22:35 PM
MOVED: Priola
MOTION: Adopt amendment L.013. The motion passed on a vote of 5-2.
SECONDED:
VOTE
Jahn
Yes
Kerr
No
Priola
Yes
Smallwood
Yes
Court
No
Neville T.
Yes
Tate
Yes
YES: 5 NO: 2 EXC: 0 ABS: 0 FINAL ACTION: PASS


BILL: SB17-203
TIME: 04:32:15 PM
MOVED: Jahn
MOTION: Refer Senate Bill 17-203, as amended, to the Committee of the Whole. The motion passed on a vote of 7-0.
SECONDED:
VOTE
Jahn
Yes
Kerr
Yes
Priola
Yes
Smallwood
Yes
Court
Yes
Neville T.
Yes
Tate
Yes
Final YES: 7 NO: 0 EXC: 0 ABS: 0 FINAL ACTION: PASS







04:40 PM



The committee recessed.








Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details